SEC Comment Letter 0000000000-23-010941 to Third Harmonic Bio, Inc. (THRD) (CIK 0001923840)
Third Harmonic Bio, Inc. (THRD) (CIK 0001923840)
Date: Oct. 4, 2023 · CIK: 0001923840 · Accession: 0000000000-23-010941
AI Filing Summary & Sentiment
File numbers found in text: 333-274823
Letter
United States securities and exchange commission logo October 4, 2023 Natalie Holles Chief Executive Officer Third Harmonic Bio, Inc. 1700 Montgomery Street, Suite 210 San Francisco, California 94111 Re:Third Harmonic Bio, Inc. Registration Statement on Form S-3 Filed October 2, 2023 File No. 333-274823 Dear Natalie Holles: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Ryan Mitteness
Show Raw Text
United States securities and exchange commission logo
October 4, 2023
Natalie Holles
Chief Executive Officer
Third Harmonic Bio, Inc.
1700 Montgomery Street, Suite 210
San Francisco, California 94111
Re:Third Harmonic Bio, Inc.
Registration Statement on Form S-3
Filed October 2, 2023
File No. 333-274823
Dear Natalie Holles:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Ryan Mitteness